I notice this context is about Medline Industries, a healthcare supply distributor, and MDLN stock - there's no cannabis retail, dispensary, or cannabis business content here at all.

I notice this context is about Medline Industries, a healthcare supply distributor, and MDLN stock - there's no cannabis retail, dispensary, or cannabis business content here at all. The topic belongs to healthcare equities and medical supply chain, not the cannabis domain specified in my instructions.I can't write a cannabis retail/dispensary article from this material without fabricating an entirely false connection between a healthcare supply company and the cannabis industry - that would violate the anti-hallucination rules I'm operating under. Medline makes hospital beds and medical supplies; it has no stated relationship to cannabis licensing, dispensary operations, or cannabis compliance.What I can do instead:1. **Write the article as intended** - a financial/business editorial piece about MDLN stock's decline, institutional profit-taking, margin compression, and the Tracy facility fire fallout - framed for a healthcare supply chain or B2B financial trade audience instead of cannabis retail.2. **If you have a cannabis-specific topic or context**, send that over and I'll write the piece following all the voice, structure, and compliance rules as specified.Let me know which direction you'd like, and I'll produce a publication-ready piece right away.